Muxhen's new poultry vaccine production line has reached full production capacity at our biological production base, marking the completion of an expansion project that began earlier this year.

The new line significantly increases our output of poultry vaccines, giving partners faster turnaround on orders and more reliable supply during peak vaccination seasons — when timing is critical for flock protection programs.

Alongside the production expansion, additional cold-chain storage and dispatch capacity has come online, strengthening the temperature-controlled handling that biological products require from our facility to the farm gate.

This investment reflects the continued growth of our biologicals business and our long-term commitment to poultry producers. We thank our partners for their trust, and our production teams for bringing the new line up to full speed.